12120341

12120341
Send Message
View as an RSS Feed
  • A (Potentially) Final Look At MannKind  [View article]
    Gates Foundation is looking to have oxytocin in third world countries. In its normal form it needs refrigeration but the inhaled form does not. There are videos of Gates talking about saving lives with the inhaled form.
    Jan 26, 2016. 05:24 PM | 1 Like Like |Link to Comment
  • MannKind CEO Shuffle Gives Bulls And Bears Things To Consider  [View article]
    deadaim, yes it is. Don't forget Asians are needle phobic, too. We need to get into the foreign markets asap. I think it will be a much easier sell.
    Jan 17, 2016. 06:06 PM | 3 Likes Like |Link to Comment
  • IDI forms sales agreement for 5M shares; severs ties with co-CEO  [View news story]
    Why let Tan go? What am I missing here?
    Jan 17, 2016. 05:20 PM | Likes Like |Link to Comment
  • Some good news for MannKind?  [View news story]
    Exactly, and the Chinese and Japanese are needle phobic, and both countries love American fast food.
    Jan 14, 2016. 01:02 AM | 4 Likes Like |Link to Comment
  • A (Potentially) Final Look At MannKind  [View article]
    What do you think an asthma inhaler does? The inhaler can be preassembled ahead of time so no need to screw with it when you are having an attack.
    Jan 14, 2016. 12:56 AM | 6 Likes Like |Link to Comment
  • MannKind CEO Shuffle Gives Bulls And Bears Things To Consider  [View article]
    I feel much better after the JPM conference today. What are others thoughts?
    Jan 14, 2016. 12:53 AM | 4 Likes Like |Link to Comment
  • MannKind CEO Shuffle Gives Bulls And Bears Things To Consider  [View article]
    jp - The second suit was brought by Elorac. Company makes a osteoarthritis cream that sny didn't put in much effort to promote according to the lawsuit.
    Jan 14, 2016. 12:52 AM | 2 Likes Like |Link to Comment
  • A (Potentially) Final Look At MannKind  [View article]
    Maybe, because Al threatened to sue? Sny already has pending suit from Genzyme shareholders and a new one from Elorac. No way could sny afford to have a third suit pending in the US claiming they sandbagged mnkd, too.
    Jan 14, 2016. 12:16 AM | Likes Like |Link to Comment
  • A (Potentially) Final Look At MannKind  [View article]
    Sny knew early on about users lowering their basal dose. I can't help but think that was one big reason to sandbag afrezza. They had too much invested in toujeo to watch it be cannibalized while only getting 65% of afrezza profits.

    Also, since Brandicourt was around for the launch of exubera, I doubt he wanted his name associated another inhaled insulin.
    Jan 13, 2016. 01:38 AM | Likes Like |Link to Comment
  • A (Potentially) Final Look At MannKind  [View article]
    Teva and Takeda are two names.
    Jan 13, 2016. 01:30 AM | 1 Like Like |Link to Comment
  • A (Potentially) Final Look At MannKind  [View article]
    Sam Finta had a conference call last week with mnkd who assured him afrezza will continue to be available. Check his twitter account for the post.
    Jan 13, 2016. 01:08 AM | Likes Like |Link to Comment
  • A (Potentially) Final Look At MannKind  [View article]
    How do you know that mnkd (Al) didn't threaten to sue knowing that sny was sandbagging? Sny knew early on that users were starting to need less lantus which would cut into sny profits. Yes, I know lantus is going generic but it would have the same effect on toujeo, too.
    Jan 13, 2016. 12:28 AM | 1 Like Like |Link to Comment
  • MannKind CEO Shuffle Gives Bulls And Bears Things To Consider  [View article]
    Sny priced the drug too high then made little effort to promote it.
    Jan 13, 2016. 12:23 AM | 9 Likes Like |Link to Comment
  • MannKind - Wait And See Or Jump The Ship?  [View article]
    Toujeo came on the market after afrezza and their ads are everywhere.
    Jan 9, 2016. 04:08 AM | 1 Like Like |Link to Comment
  • MannKind - Wait And See Or Jump The Ship?  [View article]
    Vierbacher is now heading up a VC with 1B to invest.
    Jan 9, 2016. 04:07 AM | 1 Like Like |Link to Comment
COMMENTS STATS
368 Comments
827 Likes